Stay updated on Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-28T01:41:40.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page software revision was updated to v3.4.3, replacing the previous v3.4.2. There are no observed changes to the clinical trial details, eligibility criteria, locations, or study results.
    Difference
    0.1%
    Check dated 2026-03-06T17:48:19.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:34:56.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1. No substantive content changes are evident.
    Difference
    0.1%
    Check dated 2026-02-05T14:25:44.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now displays a new revision note 'Revision: v3.3.4' replacing 'Revision: v3.3.3'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:48:40.000Z thumbnail image
  8. Check
    108 days ago
    Change Detected
    Summary
    Added a Locations section listing Florida, New Jersey, New York, and Pennsylvania. Removed the state-specific location sections and the HHS Vulnerability Disclosure, and updated the page revision to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-24T15:41:10.000Z thumbnail image

Stay in the know with updates to Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.